A new market study, titled “Global Drug Device Combination Products Market Research Report 2018”, has been featured on WiseGuyReports.
This report studies the global Drug Device Combination Products market status and forecast, categorizes the global Drug Device Combination Products market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Drug devices facilitate early diagnosis and reduced treatment duration in a majority of surgical procedures. Growing demand is also a consequence of minimal pain, heightened cost efficiency, improved safety, better efficacy, rapid recovery, and reduced hospital stay rendered by these devices.
The global drug device combination product market size is expected to reach USD 176 billion by 2024. Increasing presence of regulatory healthcare authorities enforcing clearly defined protocols for premarket authorizations is anticipated to support manufacturers in gaining approvals for their products. Recently, the U.S. FDA incorporated the lean management process mapping approach to build a more cohesive, streamlined, systematic, and collaborative system for the review of the aforementioned products. Safety guidelines and recommendations issued by these authorities are presumed to increase the adoption of these products in future and boost overall growth during the forecast period.
Severe side effects and drug interactions associated with therapeutics owing to drug absorption by unintended sites in the body are anticipated to induce need for targeted therapy, thereby propelling demand for drug-device combinations. For instance, consistent administration of Levodopa results in long-term complications such as motor fluctuations, dyskinesias, severe metabolic changes, and neurotoxic effects. These aforementioned factors drive the clinical urgency to incorporate alternatives based on targeted therapy, as in case of drug-device combination products.
The major manufacturers covered in this report
St.Jude Medical, Inc.
Boston Scientific Corporation
C.R. Bard, Inc.
W.L.Core & Associates, Inc.
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Insulin injector drug
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospitals and Clinics
The study objectives of this report are:
To analyze and study the global Drug Device Combination Products sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Drug Device Combination Products manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Drug Device Combination Products are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Drug Device Combination Products Manufacturers
Drug Device Combination Products Distributors/Traders/Wholesalers
Drug Device Combination Products Subcomponent Manufacturers
Table of Contents
1 Drug Device Combination Products Market Overview
2 Global Drug Device Combination Products Market Competition by Manufacturers
3 Global Drug Device Combination Products Capacity, Production, Revenue (Value) by Region (2013-2018)
4 Global Drug Device Combination Products Supply (Production), Consumption, Export, Import by Region (2013-2018)
5 Global Drug Device Combination Products Production, Revenue (Value), Price Trend by Type
6 Global Drug Device Combination Products Market Analysis by Application
7 Global Drug Device Combination Products Manufacturers Profiles/Analysis
8 Drug Device Combination Products Manufacturing Cost Analysis
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
11 Market Effect Factors Analysis
12 Global Drug Device Combination Products Market Forecast (2018-2025)
13 Research Findings and Conclusion
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)